Filing Analysis
📄 Other SEC Filing
Filed May 20, 2026
⚪ LOW
Biodesix, Inc. reported the voting results from its 2026 Annual Meeting of Stockholders held on May 19, 2026. Stockholders elected two Class III directors, approved executive compensation on an advisory basis, selected a one-year frequency for future advisory compensation votes, and ratified KPMG LLP as the independent auditor for 2026.
📋 Key Facts
- The Annual Meeting of Stockholders was held on May 19, 2026.
- As of the March 23, 2026 record date, there were 10,107,219 shares of common stock outstanding and entitled to vote.
- Jean Franchi and Hany Massarany were elected as Class III directors to serve until the 2029 annual meeting.
- Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
📢 Regulation FD Disclosure
Filed May 04, 2026
⚪ LOW
Biodesix, Inc. announced its financial and operating results for the first quarter ended March 31, 2026, via a press release. The filing serves as a standard quarterly earnings disclosure under Item 2.02.
📋 Key Facts
- The report was filed on May 4, 2026, covering the fiscal quarter ended March 31, 2026.
- The financial results were disclosed through a press release furnished as Exhibit 99.1.
- The information in the filing is furnished under Item 2.02 and is not deemed 'filed' for Section 18 purposes.
📢 Regulation FD Disclosure
Filed Feb 26, 2026
⚪ LOW
Biodesix, Inc. announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2025. The announcement was made via a press release furnished with the filing.
📋 Key Facts
- Announced Q4 and full year 2025 financial results on February 26, 2026.
- The filing includes Item 2.02 (Results of Operations and Financial Condition).
- A press release was furnished as Exhibit 99.1.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.